Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.

[1]  E. Degerman,et al.  Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta. , 1991, Biochemical pharmacology.

[2]  E. Degerman,et al.  Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation. , 1991, The Journal of biological chemistry.

[3]  R. Davis,et al.  A two-cycle immunoprecipitation procedure for reducing nonspecific protein contamination. , 1991, Analytical biochemistry.

[4]  E. Degerman,et al.  Relaxant effects of the selective phosphodiesterase inhibitors milrinone and OPC 3911 on isolated human mesenteric vessels. , 1989, Pharmacology & toxicology.

[5]  P. Silver,et al.  Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries , 1989, Journal of cardiovascular pharmacology.

[6]  R. Bentley,et al.  Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. , 1988, The Journal of pharmacology and experimental therapeutics.

[7]  J. Beavo,et al.  Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. , 1988, The Journal of biological chemistry.

[8]  E. G. Loten,et al.  Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver. , 1988, European journal of biochemistry.

[9]  R. Bentley,et al.  Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. , 1988, European journal of pharmacology.

[10]  M. Cohen,et al.  In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. , 1987, The Journal of pharmacology and experimental therapeutics.

[11]  A. Newman,et al.  Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. , 1987, The Journal of biological chemistry.

[12]  M. Houslay,et al.  The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. , 1987, The Biochemical journal.

[13]  C. Stoscheck,et al.  Protein assay sensitive at nanogram levels. , 1987, Analytical biochemistry.

[14]  J. Drazen,et al.  Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery. , 1986, The Journal of pharmacology and experimental therapeutics.

[15]  C. Lugnier,et al.  Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. , 1986, Biochemical pharmacology.

[16]  H. Schweiger,et al.  Increased sensitivity in antigen detection during immunoblot analysis resulting from antigen enrichment via immunoprecipitation. , 1986, Analytical biochemistry.

[17]  J. Beavo,et al.  Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. , 1986, Molecular pharmacology.

[18]  D. B. Evans,et al.  Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. , 1986, Biochemical pharmacology.

[19]  R. Colman,et al.  Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. , 1984, Biochemistry.

[20]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[22]  B. Davis.  DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS * , 1964, Annals of the New York Academy of Sciences.

[23]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[24]  P. Tarroux,et al.  Improvement and simplification of low‐background silver staining of proteins by using sodium dithionite , 1988, Electrophoresis.

[25]  M. Hagiwara,et al.  Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. , 1988, Pharmacology.

[26]  E. Braunwald,et al.  Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. , 1986, Circulation.

[27]  R. Cody,et al.  Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure. , 1986, Circulation.